Insider holders · CIK 0001592288
Dimension Therapeutics, Inc. · DMTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| OrbiMed Capital GP V LLCDirector | — | 5,397,698 | 5,397,698 | Oct 29, 2015 · 6:15 pm EDT | Form 4 |
| Rishi GuptaDirector | — | 5,397,698 | 5,397,698 | Oct 29, 2015 · 6:14 pm EDT | Form 4 |
| ORBIMED ADVISORS LLCDirector | — | 5,397,698 | 5,397,698 | Oct 29, 2015 · 6:15 pm EDT | Form 4 |
| Samuel D IsalyDirector | — | 5,397,698 | 5,397,698 | Oct 29, 2015 · 6:15 pm EDT | Form 4 |
| Michael DybbsDirector | — | 2,059,283 | 2,059,283 | Oct 29, 2015 · 6:14 pm EDT | Form 4 |
| K. Reed ClarkSVP of Pharmaceutical Develop | 0 | — | 0 | Jun 8, 2016 · 8:34 pm EDT | Form 4 |
| Samuel C. WadsworthChief Scientific Officer | 0 | — | 0 | Nov 7, 2017 · 5:12 pm EST | Form 4 |
| FMR LLCrelationship not stated | — | 0 | 0 | Nov 9, 2017 · 5:01 pm EST | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.